SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 170 | -85.9% | 0.00% | – |
Q1 2022 | $2,000 | -60.0% | 1,208 | -70.2% | 0.00% | – |
Q4 2021 | $5,000 | -64.3% | 4,049 | -39.4% | 0.00% | – |
Q3 2021 | $14,000 | -65.0% | 6,687 | -38.1% | 0.00% | – |
Q2 2021 | $40,000 | +29.0% | 10,802 | +13.3% | 0.00% | – |
Q1 2021 | $31,000 | -11.4% | 9,532 | -6.0% | 0.00% | – |
Q4 2020 | $35,000 | -7.9% | 10,143 | +4.5% | 0.00% | – |
Q3 2020 | $38,000 | +22.6% | 9,705 | +1.5% | 0.00% | – |
Q2 2020 | $31,000 | +14.8% | 9,562 | -20.6% | 0.00% | – |
Q1 2020 | $27,000 | -18.2% | 12,040 | +34.9% | 0.00% | – |
Q4 2019 | $33,000 | -65.6% | 8,927 | -23.0% | 0.00% | – |
Q3 2019 | $96,000 | +5.5% | 11,600 | +10.0% | 0.00% | – |
Q2 2019 | $91,000 | +75.0% | 10,544 | +118.2% | 0.00% | – |
Q1 2019 | $52,000 | -13.3% | 4,833 | -29.7% | 0.00% | – |
Q4 2018 | $60,000 | -42.3% | 6,874 | +11.3% | 0.00% | – |
Q3 2018 | $104,000 | +1.0% | 6,176 | +26.2% | 0.00% | – |
Q2 2018 | $103,000 | +43.1% | 4,893 | +9.4% | 0.00% | – |
Q1 2018 | $72,000 | +20.0% | 4,474 | +40.8% | 0.00% | – |
Q4 2017 | $60,000 | +650.0% | 3,177 | +459.3% | 0.00% | – |
Q3 2017 | $8,000 | +300.0% | 568 | +153.6% | 0.00% | – |
Q2 2017 | $2,000 | +100.0% | 224 | +111.3% | 0.00% | – |
Q1 2017 | $1,000 | -85.7% | 106 | -91.3% | 0.00% | – |
Q4 2015 | $7,000 | -81.6% | 1,215 | -80.7% | 0.00% | – |
Q3 2015 | $38,000 | +375.0% | 6,292 | +417.9% | 0.00% | – |
Q2 2015 | $8,000 | -84.0% | 1,215 | -85.4% | 0.00% | – |
Q1 2015 | $50,000 | -35.1% | 8,300 | -25.0% | 0.00% | – |
Q4 2014 | $77,000 | -21.4% | 11,067 | -9.0% | 0.00% | – |
Q3 2014 | $98,000 | 0.0% | 12,163 | 0.0% | 0.00% | – |
Q2 2014 | $98,000 | +3.2% | 12,163 | 0.0% | 0.00% | – |
Q1 2014 | $95,000 | +400.0% | 12,163 | +480.3% | 0.00% | – |
Q4 2013 | $19,000 | -24.0% | 2,096 | -28.5% | 0.00% | – |
Q3 2013 | $25,000 | +13.6% | 2,930 | 0.0% | 0.00% | – |
Q2 2013 | $22,000 | – | 2,930 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |